Bollard Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Buy |
17,711
+58
| +0.3% | +$5.18K | 0.06% | 91 |
|
|
2026
Q1 | $1.27M | Buy |
17,653
+157
| +0.9% | +$12.1K | 0.04% | 101 |
|
|
2025
Q4 | $1.39M | Sell |
17,496
-4,925
| -22% | -$388K | 0.03% | 96 |
|
|
2025
Q3 | $1.69M | Buy |
22,421
+230
| +1% | +$15.8K | 0.04% | 98 |
|
|
2025
Q2 | $1.53M | Buy |
22,191
+457
| +2% | +$30K | 0.04% | 101 |
|
|
2025
Q1 | $1.47M | Buy |
21,734
+252
| +1% | +$15.1K | 0.04% | 96 |
|
|
2024
Q4 | $964K | Sell |
21,482
-7,328
| -25% | -$411K | 0.03% | 110 |
|
|
2024
Q3 | $1.81M | Buy |
28,810
+228
| +0.8% | +$13.3K | 0.05% | 94 |
|
|
2024
Q2 | $1.69M | Buy |
28,582
+205
| +0.7% | +$12.8K | 0.05% | 90 |
|
|
2024
Q1 | $2.26M | Buy |
28,377
+186
| +0.7% | +$14.2K | 0.07% | 79 |
|
|
2023
Q4 | $2.23M | Buy |
28,191
+184
| +0.7% | +$13.1K | 0.08% | 74 |
|
|
2023
Q3 | $1.96M | Sell |
28,007
-59
| -0.2% | -$4.18K | 0.07% | 81 |
|
|
2023
Q2 | $1.94M | Buy |
28,066
+122
| +0.4% | +$8.68K | 0.07% | 90 |
|
|
2023
Q1 | $2.08M | Buy |
27,944
+7,526
| +37% | +$631K | 0.08% | 86 |
|
|
2022
Q4 | $1.9M | Buy |
20,418
+22
| +0.1% | +$2.12K | 0.07% | 90 |
|
|
2022
Q3 | $1.95M | Sell |
20,396
-388
| -2% | -$38.4K | 0.08% | 90 |
|
|
2022
Q2 | $1.93M | Buy |
20,784
+117
| +0.6% | +$11.4K | 0.08% | 95 |
|
|
2022
Q1 | $2.09M | Buy |
20,667
+105
| +0.5% | +$11K | 0.07% | 109 |
|
|
2021
Q4 | $2.12M | Buy |
20,562
+114
| +0.6% | +$10.5K | 0.07% | 104 |
|
|
2021
Q3 | $1.74M | Buy |
20,448
+122
| +0.6% | +$10.2K | 0.06% | 105 |
|
|
2021
Q2 | $1.7M | Buy |
20,326
+131
| +0.6% | +$10.7K | 0.05% | 106 |
|
|
2021
Q1 | $1.52M | Buy |
20,195
+114
| +0.6% | +$8.3K | 0.05% | 106 |
|
|
2020
Q4 | $1.37M | Sell |
20,081
-88
| -0.4% | -$5.72K | 0.05% | 106 |
|
|
2020
Q3 | $1.18M | Buy |
20,169
+129
| +0.6% | +$8.03K | 0.04% | 111 |
|
|
2020
Q2 | $1.3M | Buy |
20,040
+2,800
| +16% | +$176K | 0.05% | 103 |
|
|
2020
Q1 | $1.02M | Sell |
17,240
-1,344
| -7% | -$89.7K | 0.05% | 103 |
|
|
2019
Q4 | $1.38M | Buy |
18,584
+21
| +0.1% | +$1.48K | 0.04% | 112 |
|
|
2019
Q3 | $1.17M | Buy |
18,563
+24
| +0.1% | +$1.42K | 0.04% | 117 |
|
|
2019
Q2 | $1.01M | Buy |
18,539
+24
| +0.1% | +$1.29K | 0.03% | 134 |
|
|
2019
Q1 | $998K | Buy |
18,515
+21
| +0.1% | +$1.3K | 0.04% | 130 |
|
|
2018
Q4 | $1.21M | Buy |
18,494
+719
| +4% | +$53.7K | 0.05% | 123 |
|
|
2018
Q3 | $1.4M | Buy |
17,775
+20
| +0.1% | +$1.43K | 0.06% | 120 |
|
|
2018
Q2 | $1.14M | Buy |
17,755
+19
| +0.1% | +$1.25K | 0.05% | 121 |
|
|
2018
Q1 | $1.1M | Buy |
17,736
+17
| +0.1% | +$1.22K | 0.05% | 128 |
|
|
2017
Q4 | $1.28M | Sell |
17,719
-1,522
| -8% | -$111K | 0.06% | 117 |
|
|
2017
Q3 | $1.56M | Sell |
19,241
-174
| -0.9% | -$13.8K | 0.08% | 117 |
|
|
2017
Q2 | $1.56M | Buy |
19,415
+25
| +0.1% | +$1.97K | 0.08% | 120 |
|
|
2017
Q1 | $1.52M | Buy |
19,390
+1,976
| +11% | +$158K | 0.09% | 117 |
|
|
2016
Q4 | $1.37M | Buy |
17,414
+564
| +3% | +$45.6K | 0.09% | 115 |
|
|
2016
Q3 | $1.5M | Buy |
16,850
+1,812
| +12% | +$171K | 0.1% | 110 |
|
|
2016
Q2 | $1.44M | Buy |
15,038
+8
| +0.1% | +$797 | 0.1% | 109 |
|
|
2016
Q1 | $1.56M | Buy |
15,030
+9
| +0.1% | +$875 | 0.13% | 95 |
|
|
2015
Q4 | $1.47M | Buy |
15,021
+6
| +0% | +$588 | 0.12% | 98 |
|
|
2015
Q3 | $1.45M | Buy |
15,015
+46
| +0.3% | +$4.84K | 0.12% | 110 |
|
|
2015
Q2 | $1.57M | Sell |
14,969
-4,911
| -25% | -$502K | 0.12% | 113 |
|
|
2015
Q1 | $2.05M | Buy |
19,880
+69
| +0.3% | +$6.98K | 0.15% | 96 |
|
|
2014
Q4 | $1.91M | Buy |
19,811
+51
| +0.3% | +$4.49K | 0.17% | 90 |
|
|
2014
Q3 | $1.57M | Buy |
19,760
+419
| +2% | +$33K | 0.15% | 110 |
|
|
2014
Q2 | $1.46M | Buy |
19,341
+10
| +0.1% | +$756 | 0.14% | 114 |
|
|
2014
Q1 | $1.45M | Buy |
19,331
+11
| +0.1% | +$777 | 0.15% | 83 |
|
|
2013
Q4 | $1.38M | Buy |
19,320
+9
| +0% | +$578 | 0.15% | 80 |
|
|
2013
Q3 | $1.1M | Buy |
19,311
+12,597
| +188% | +$751K | 0.13% | 83 |
|
|
2013
Q2 | $384K | Buy |
+6,714
| New | +$389K | 0.07% | 113 |
|
Other funds holding CVS
Bollard Group's CVS Position: Q2 2026 in Review
Bollard Group increased its CVS Health (CVS) stake by 0.33% in Q2 2026, buying an estimated $5.18K and bringing the position to 17,711 shares worth $1.83M. The position accounts for 0.06% of the portfolio, ranked #91.
Bollard Group first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.26M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Bollard Group held 17,711 shares of CVS Health worth $1.83M as of Q2 2026.
- Bollard Group bought 58 CVS Health shares in Q2 2026, an estimated $5.18K.
- CVS Health made up 0.06% of Bollard Group's portfolio in Q2 2026, its #91 holding.
- Bollard Group first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Bollard Group's CVS Health position peaked at $2.26M in Q1 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.